Category: Infections and Diseases

Antimicrobial Resistance: Updates from WHO

Key facts Antimicrobial resistance (AMR) threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi. AMR is an increasingly serious threat to global public health that requires action across all government sectors and society. Without effective antibiotics, the success of major surgery and cancer chemotherapy would […]

Passive Antibody Therapy

In 1890, Emil Behring and Shibasaburo Kitasato reported an extraordinary experiment. They immunized rabbits with tetanus and then collected serum from these animals. Subsequently, they injected 0.2 ml of the immune serum into the abdominal cavity of six mice. After 24 hours, they infected the treated animals and untreated controls with live, virulent tetanus bacteria. […]

Introduction to Molecular Diagnoses under MGC Partnership

MicroBiotics, in partnership with GeneLab and the Laboratory Resources Unit of Christcov Nigeria Limited, are proud to introduce our services of reliable, affordable, and efficient molecular laboratory to you. This vision was borne out of the observation that hospitals find it very difficult to navigate the herculean task of molecular diagnosis of infectious diseases. This […]

The Initiation of Infection and the Cause of Disease (Part 3): Disseminated and Opportunistic Infections

In the field of infectious diseases, two of the most dreaded types of infection are disseminated infections and opportunistic infections. Without these two forms of infections, most diseases would easily be resolved. Co-infection is another complication, but we’ll discuss that at another date.

The Initiation of Infection and the Causes of Disease (Part 1): Factors Determining Infections

Before any individual can be infected, there must be a point of entry. For us humans, most of our sense organs are point of entry for microorganisms, and they also double as initiation point for infection most times. Hence, we have the following entry points for infective microorganisms: mouth, ear, nose, eyes, skin and sex organs (genitalia).

RNA Interference: A Promising Approach for the Treatment of Hepatitis B Virus (HBV) Infection

HBV infection is global health problem with over 350 million HBV carriers worldwide and over one million deaths occurring annually. Current therapy which includes IFN-alpha and nucleoside analogs such as lamivudine are partially effective. And that’s where RNA Interference comes in.

The Threat of Infection from Potential Agents of Bioterrorism

With Liberia recently declared free of Ebola virus infection, and the trailing of the catastrophe with allegations of failed experimentation of bioterrorism agents, this article, written when the world is just taking note of bioterrorism agents, takes a cursory look at past events in order for us to prepare for the unknown and delicate future filled with infectious agents with bioterrorism potentials.